Fingerprint
Dive into the research topics of 'Development of nanoliposomal irinotecan (nal-IRI, MM-398, PEP02) in the management of metastatic pancreatic cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Development of nanoliposomal irinotecan (nal-IRI, MM-398, PEP02) in the management of metastatic pancreatic cancer
Nai Jung Chiang, Jang Yang Chang, Yan Shen Shan, Li Tzong Chen
Research output: Contribution to journal › Review article › peer-review
16
Citations
(Scopus)